Opioid Policies

collage

Much like the rest of the United States, residents of the District of Columbia are struggling with substance use disorder (SUD) rate increases and high rates of opioid-related deaths. Unfortunately, these are multi-faceted issues that require year-long initiatives and systematic programs to address the myriad causes of addiction.

MSDC stands as a partner to the District government and private entities to help arrest the rates of opioid and substance abuse in the District. Through our advocacy for better prescribing practices, education on addiction, and even helping our own community through our Physician Health Program, MSDC is working to make DC a leader in reducing SUD, OUD, and addiction.

On a related note, MSDC is passionate about helping patients make prescriptions and medication more affordable. Whether expanding access to biosimilars or advocating for more affordable co-pays, MSDC wants to help our patients afford the medications they need.

MSDC Statement and Testimony on Opioid and Prescription Issues

25th Council information coming soon

 

MSDC and Coalition Request Prior Auth Hearing

May 18, 2022, 11:39 AM by MSDC Staff
The letter signed by numerous national and local associations requests a hearing on B24-655 before the Council's summer recess.

Today, MSDC and a coalition of 17 other organizations requested that the Committee on Health hold a hearing on B24-655 (Prior Authorization Reform Act) before the Council's summer recess.

The bill would align DC with other states in reforming the prior authorization process and adopt common-sense reforms modeled by the American Medical Association and other national healthcare organizations. The bill lays out a minimum amount of time a prescription approval is valid, sets qualifications for payer personnel to make prior auth determinations, prohibits a prior auth for cost purposes, and more. The bill is one of MSDC's highest priorities and we have created an action site on the issue.

The letter (seen below) is joined by national and local healthcare, patient advocacy, and health reform organizations. The content is simple in asking for a hearing as the organizations involved have numerous stories on the impact of prior authorization on their members and patients. MSDC has some examples on its prior auth site.

How can you get involved in this issue?

Let MSDC know you want to get involved via our form

Contact your Councilmembers and tell them to support the bill

Letter:

May 18, 2022

The Honorable Vincent C. Gray
Chair, Committee on Health
1350 Pennsylvania Ave NW Ste 406
Washington, DC 20004

Dear Chair Gray,

We, the undersigned organizations and practices, request that you hold a hearing on B24-655, the Prior Authorization Reform Amendment Act of 2022, before the Council’s summer recess. This legislation is critical to protecting the health and wellbeing of District residents and joins the District with numerous other states in reforming the onerous prior authorization process.

Prior authorizations routinely negatively impact patient care. The recent American Medical Association physician survey on prior auth showed that 93% of physicians report care delays because of prior authorization. The same survey showed that provider offices spend 13 hours each week (almost two business days) dedicated to prior auth paperwork. These delays impact our residents and patients daily, leading many to wait unnecessarily for their treatments or choose to abandon them altogether. 

Our organizations have stories from patients and providers that can help educate the committee on this issue, but without a hearing on the bill we cannot share this information before the committee. We urge you to schedule a hearing for this bill and give us the chance to share why this important reform is needed now.

Sincerely,
 

Medical Society of the District of Columbia
Aimed Alliance 
Allergy & Asthma Network
The ALS Association
American College of Rheumatology
American Medical Association
Arthritis Foundation
The Association for Clinical Oncology 
Chronic Disease Coalition
DC Society of Addiction Medicine
District of Columbia Primary Care Association
Hemophilia Association of the Capital Area
Hemophilia Federation of America
Lupus and Allied Diseases Association
Multiple Sclerosis Association of America
National Multiple Sclerosis Society
Rheumatism Society of DC
Washington Psychiatric Society
 

CC: Members of the Committee on Health

 

Load more comments
avatar
New code

Sample of Legislation MSDC Tracked on Opioid and Prescription Policy

 

Access to Biosimilars Amendment Act (B23-430)

What does it do? The bill authorizes licensed pahrmacists to dispense interchangeable biological products and requires notifications to physicians when such interchangeables are dispensed.

MSDC position: MSDC has a position of priority support on this legislation, identifying its passage as one of its highest legislative priorities.

Current status: SUCCESS. The bill was passed by the Council and signed by the Mayor.

Opioid Labeling Amendment Act (B23-535)

What does it do? The bill requires prescription opioid medications to include a statement that the drug is an opioid and opioids may cause dependence, addiction, or overdoes.

MSDC position: MSDC supports the legislation.

Current status: The bill had a hearing before the Committee on Health on July 29, 2020. MSDC leader Dr. Sam Kareff testified for the Medical Society. It passed the Council on November 10 and was signed by the Mayor December 7.

Pre-exposure Prophylaxis Insurance Discrimination Amendment Act (B23-36)

What does it do? The bill prohibits insurance companies from factoring the use of PreP in decisions related to disability, life, or long-term care policies.

MSDC position: MSDC supports this legislation

Current status: The bill was introduced on January 8, 2019 and assigned to the Committee on Business and Economic Development.